Giuseppe L, Fabian SG, Gianfranco C. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16:217–221.
Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120:1501–17.
Google Scholar
Peyronnet R, Ravens U. Atria-selective antiarrhythmic drugs in need of alliance partners. Pharmacol Res. 2019;145:104262.
Google Scholar
Calvo D, Filgueiras-Rama D, Jalife J. Mechanisms and drug development in atrial fibrillation. Pharm Rev. 2018;70:505–25.
Google Scholar
Roselli C, Rienstra M, Ellinor PT. Genetics of atrial fibrillation in 2020: GWAS, genome sequencing, polygenic risk, and beyond. Circ Res. 2020;127:21–33.
Google Scholar
Zou R, Zhang D, Lv L, Shi W, Song Z, Yi B, et al. Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke. J Transl Med. 2019;17:45.
Google Scholar
Damås JK, Eiken HG, Oie E, Bjerkeli V, Yndestad A, Ueland T, et al. Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovasc Res. 2000;47:778–87.
Google Scholar
Segret A, Rücker-Martin C, Pavoine C, Flavigny J, Deroubaix E, Châtel MA, et al. Structural localization and expression of CXCL12 and CXCR4 in rat heart and isolated cardiac myocytes. J Histochem Cytochem. 2007;55:141–50.
Google Scholar
Pozzobon T, Goldoni G, Viola A, Molon B. CXCR4 signaling in health and disease. Immunol Lett. 2016;177:6–15.
Google Scholar
Döring Y, Pawig L, Weber C, Noels H. The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease. Front Physiol. 2014;5:212.
Google Scholar
Yu L, Cecil J, Peng SB, Schrementi J, Kovacevic S, Paul D, et al. Identification and expression of novel isoforms of human stromal cell-derived factor. Gene. 2006;374:174–9.
Google Scholar
Kawaguchi N, Zhang TT, Nakanishi T. Involvement of CXCR4 in normal and abnormal development. Cells. 2019;8:185.
Google Scholar
Goette A, Jentsch-Ullrich K, Lendeckel U, Röcken C, Agbaria M, Auricchio A, et al. Effect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide? Circulation. 2003;108:2446–9.
Google Scholar
Li D, Bjørnager L, Langkilde A, Andersen O, Jøns C, Agner BF, et al. Stromal cell-derived factor 1α (SDF-1α): A marker of disease burden in patients with atrial fibrillation. Scand Cardiovasc J. 2016;50:36–41.
Google Scholar
Wang XX, Zhang FR, Zhu JH, Xie XD, Chen JZ. Up-regulation of CXC chemokine receptor 4 expression in chronic atrial fibrillation patients with mitral valve disease may be attenuated by renin-angiotensin system blockers. J Int Med Res. 2009;37:1145–51.
Google Scholar
Barth AS, Merk S, Arnoldi E, Zwermann L, Kloos P, Gebauer M, et al. Functional profiling of human atrial and ventricular gene expression. Pflug Arch. 2005;450:201–8.
Google Scholar
Adam O, Lavall D, Theobald K, Hohl M, Grube M, Ameling S, et al. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. J Am Coll Cardiol. 2010;55:469–80.
Google Scholar
Yeh YH, Kuo CT, Lee YS, Lin YM, Nattel S, Tsai FC, et al. Region-specific gene expression profiles in the left atria of patients with valvular atrial fibrillation. Heart rhythm. 2013;10:383–91.
Google Scholar
Tsai FC, Lin YC, Chang SH, Chang GJ, Hsu YJ, Lin YM, et al. Differential left-to-right atria gene expression ratio in human sinus rhythm and atrial fibrillation: Implications for arrhythmogenesis and thrombogenesis. Int J Cardiol. 2016;222:104–12.
Google Scholar
Chen Z, McGee M, Liu Q, Scheuermann RH. A distribution free summarization method for Affymetrix GeneChip arrays. Bioinformatics. 2007;23:321–7.
Google Scholar
Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249–64.
Google Scholar
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.
Google Scholar
Kolde R, Laur S, Adler P, Vilo J. Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics. 2012;28:573–80.
Google Scholar
Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–7.
Google Scholar
Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607–d613.
Google Scholar
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8:S11. Suppl 4
Google Scholar
Zhao ZY, Guo YM. CaCl2-ACh induced atrial fibrillation (flutter) in mice. Acta pharmacologica Sin. 1982;3:185–8.
Google Scholar
Zhou Q, Chen B, Chen X, Wang Y, Ji J, Kizaibek M, et al. Arnebiae Radix prevents atrial fibrillation in rats by ameliorating atrial remodeling and cardiac function. J Ethnopharmacol. 2020;248:112317.
Google Scholar
Lv X, Li J, Hu Y, Wang S, Yang C, Li C, et al. Overexpression of miR-27b-3p targeting Wnt3a regulates the signaling pathway of Wnt/-catenin and attenuates atrial fibrosis in rats with atrial fibrillation. Oxid Med Cell Longev. 2019;2019:5703764.
Google Scholar
Wang C, Chen W, Shen J. CXCR7 targeting and its major disease r. Front Pharm. 2018;9:641.
Bordenave J, Thuillet R, Tu L, Phan C, Cumont A, Marsol C, et al. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats. Circ Res. 2020;116:686–97.
Google Scholar
Chu PY, Joshi MS, Horlock D, Kiriazis H, Kaye DM. CXCR4 antagonism reduces cardiac fibrosis and improves cardiac performance in dilated cardiomyopathy. Front Pharmacol. 2019;10:117.
Google Scholar
Schrickel JW, Bielik H, Yang A, Schimpf R, Shlevkov N, Burkhardt D, et al. Induction of atrial fibrillation in mice by rapid transesophageal atrial pacing. Basic Res Cardiol. 2002;97:452–60.
Google Scholar
Maria Z, Campolo AR, Scherlag BJ, Ritchey JW, Lacombe VA. Dysregulation of insulin-sensitive glucose transporters during insulin resistance-induced atrial fibrillation. Biochim Biophys Acta Mol Basis Dis. 2018;1864:987–96.
Google Scholar
Zhang N, An X, Lang P, Wang F, Xie Y. Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro. Biomed Pharmacother. 2019;109:1016–23.
Google Scholar
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25:402–8.
Google Scholar
Lin CS, Pan CH. Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation. CMLS. 2008;65:1489–508.
Google Scholar
Nattel S. Molecular and Cellular Mechanisms of Atrial Fibrosis in Atrial Fibrillation. JACC Clin Electrophysiol. 2017;3:425–35.
Google Scholar
Balestrieri ML, Balestrieri A, Mancini FP, Napoli C. Understanding the immunoangiostatic CXC chemokine network. Cardiovasc Res. 2008;78:250–6.
Google Scholar
Huang J, Wu N, Xiang Y, Wu L, Li C, Yuan Z, et al. Prognostic value of chemokines in patients with newly diagnosed atrial fibrillation. Int J Cardiol. 2020;320:83–89.
Google Scholar
Zhang YL, Teng F, Han X, Li PB, Yan X, Guo SB, et al. Selective blocking of CXCR2 prevents and reverses atrial fibrillation in spontaneously hypertensive rats. J Cell Mol Med. 2020;24:11272–82.
Google Scholar
Zhang YL, Cao HJ, Han X, Teng F, Chen C, Yang J, et al. Chemokine Receptor CXCR-2 Initiates Atrial Fibrillation by Triggering Monocyte Mobilization in Mice. Hypertension. 2020;76:381–92.
Google Scholar
Zhang J, Huang X, Wang X, Gao Y, Liu L, Li Z, et al. Identification of potential crucial genes in atrial fibrillation: a bioinformatic analysis. BMC Med Genomics. 2020;13:104.
Google Scholar
Fricker SP, Anastassov V, Cox J, Darkes MC, Grujic O, Idzan SR, et al. Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4. Biochem Pharm. 2006;72:588–96.
Google Scholar
Liu Y, Shi Q, Ma Y, Liu Q. The role of immune cells in atrial fibrillation. J Mol Cell Cardiol. 2018;123:198–208.
Google Scholar
Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12:230–43.
Google Scholar
Yamashita T, Sekiguchi A, Iwasaki YK, Date T, Sagara K, Tanabe H, et al. Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J. 2010;74:262–70.
Google Scholar
Liu L, Lee J, Fu G, Liu X, Wang H, Zhang Z, et al. Activation of Peripheral Blood CD3 (+) T-lymphocytes in Patients With Atrial Fibrillation. Int Heart J. 2012;53:221–4.
Google Scholar
Guo Y, Lip GY, Apostolakis S. Inflammation in Atrial Fibrillation. J Am Coll Cardiol. 2012;60:2263–70.
Google Scholar
Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028–40.
Google Scholar
Wang Y, Dembowsky K, Chevalier E, Stüve P, Korf-Klingebiel M, Lochner M, et al. C-X-C motif chemokine receptor 4 blockade promotes tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function. Circulation. 2019;139:1798–812.
Google Scholar
Chu PY, Walder K, Horlock D, Williams D, Nelson E, Byrne M, et al. CXCR4 antagonism attenuates the development of diabetic cardiac fibrosis. PLoS ONE. 2015;10:e0133616.
Google Scholar
Van den Bos EJ, Constantinescu AA, van Domburg RT, Akin S, Jordaens LJ, Kofflard MJ. Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation. Eur Heart J. 2011;32:611–7.
Google Scholar
Hu X, Dai S, Wu WJ, Tan W, Zhu X, Mu J, et al. Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation. 2007;116:654–63.
Google Scholar
Zou D, Geng N, Chen Y, Ren L, Liu X, Wan J, et al. Ranolazine improves oxidative stress and mitochondrial function in the atrium of acetylcholine-CaCl2 induced atrial fibrillation rats. Life Sci. 2016;156:7–14.
Google Scholar
Goette A, Staack T, Röcken C, Arndt M, Geller JC, Huth C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol. 2000;35:1669–77.
Google Scholar
Meijering RAM, Wiersma M, Zhang D, Lanters EAH, Hoogstra-Berends F, Scholma J, et al. Application of kinomic array analysis to screen for altered kinases in atrial fibrillation remodeling. Heart Rhythm. 2018;15:1708–16.
Google Scholar
Wiersma M, Meijering RAM, Qi XY, Zhang D, Liu T, Hoogstra-Berends F, et al. Endoplasmic reticulum stress is associated with autophagy and cardiomyocyte remodeling in experimental and human atrial fibrillation. J Am Heart Assoc. 2017;6:e006458.
Google Scholar
Zhao QD, Viswanadhapalli S, Williams P, Shi Q, Tan C, Yi X, et al. NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways. Circulation. 2015;131:643–55.
Google Scholar
Jackson EK, Zhang Y, Gillespie DD, Zhu X, Cheng D, Jackson TC. SDF-1α (stromal cell-derived factor 1α) induces cardiac fibroblasts, renal microvascular smooth muscle cells, and glomerular mesangial cells to proliferate, cause hypertrophy, and produce collagen. J Am Heart Assoc. 2017;6:e007253.
Google Scholar
Polyakova V, Miyagawa S, Szalay Z, Risteli J, Kostin S. Atrial extracellular matrix remodelling in patients with atrial fibrillation. BMC Cardiovasc Disord. 2008;12:189–208.
Google Scholar
Nakano Y, Niida S, Dote K, Takenaka S, Hirao H, Miura F, et al. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J Am Coll Cardiol. 2004;43:818–25.
Google Scholar
Xu D, Li R, Wu J, Jiang L, Zhong HA. Drug design targeting the CXCR4/CXCR7/CXCL12 Pathway. Curr Top Med Chem. 2016;16:1441–51.
Google Scholar
Huynh C, Dingemanse J, Meyer Zu Schwabedissen HE, Sidharta PN. Relevance of the CXCR4/CXCR7-CXCL12 axis and its effect in pathophysiological conditions. Pharm Res. 2020;161:105092.
Google Scholar
